What It Is
The Gold Standard in Hair Regeneration
Regenera Activa is a medical procedure that uses the patented Rigenera® EVO device to produce an autologous micrograft solution from the patient’s own tissue — containing progenitor cells, smart exosomes, and extracellular matrix.
Injected into the scalp, this biological cocktail targets dormant hair follicles, reducing inflammation, reactivating the growth cycle, and improving hair density and thickness.
- No surgery, no scarring
- Results visible from 3 months
- Suitable for men and women
- Complements hair transplant procedures
- Supported by 80+ peer-reviewed studies
Autologous Micrografting
How is AMT Done?
Diagnosis
Preparation &
Anaesthesia
Extraction
Disaggregation &
Collection
Infiltration
What are the benefits?
The AMT® protocol is indicated for patients experiencing androgenetic alopecia at various stages, and can be combined with other treatments for enhanced outcomes.
Contact Us
Protocol Overview
From Consultation to Results
Medical Assessment
Physician evaluates AGA stage, patient history, and suitability for the procedure.
Scalp Preparation
Local anaesthetic applied to donor area (retroauricular region).
Biopsy & Processing
Tissue processed through Rigenera® EVO in under 2 minutes.
Microinjection
AMT® solution injected into affected scalp zones.
Post-Procedure
No downtime. Patient can resume normal activities immediately.
Follow-up
Review at 3, 6, and 12 months. Annual session recommended.
Explore the Clinical Evidence
Over 80 peer-reviewed publications validate the safety and efficacy of the AMT® procedure. Access our full scientific library.
View Scientific Library